ADEMEX: The evidence and the nephrosopher

Peritoneal Dialysis International

Volumn 27, Issue 3, 2007, Pages 234-237

  Mujais, Salim ^a   Vonesh, Edward ^a  

^a BAXTER HEALTHCARE CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ANEMIA; ARTICLE; CAUSE OF DEATH; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; DIALYSATE; DISEASE CONTROL; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; MEDICAL EDUCATION; MEXICO; PERITONEAL DIALYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; SURVIVAL RATE; TREATMENT OUTCOME; UREMIA;

EID: 34447301229     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700304     Document Type: Article

References (28)

1. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307-20.
2. Paniagua R, Amato D, Vonesh E, Guo A, Mujais S. Health-related quatity of life predicts outcomes butis not affected by peritoneal clearance: the ADEMEX trial. Kidney Int 2005; 67:1093-104.
3. Burkart JM. The ADEMEX study and its implications for peritoneal dialysis adequacy. Semin Dial 2003; 16:1-4.
4. Burkart JM. The ADEMEX study and PD adequacy. Blood Purif 2003; 21:37-41.
5. Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, et al.; the HEMO Study Group. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010-19.
6. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
7. Blake PG. A critique of the Canada/USA (CANUSA) peritoneal dialysis study. Perit Dial Int 1996; 16:243-5.
8. Korevaar JC, Jansen MA, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT. Evaluation of DOQI guidelines: early start of dialysis treatment is not associated with better health-related quality of life. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 2002; 39:108-15.
9. Uribarri J. DOQI guidelines for nutrition in long-term peritoneal dialysis patients: a dissenting view. Am J Kidney Dis 2001; 37:1313-18.
10. Blake PG. Comparison between DOQI and Canadian guidelines for peritoneal dialysis. Perit Dial Int 2000; 20: 487-92.
11. Blake PG. A review of the DOGI recommendations for peritoneal dialysis. Dialysis Outcome Quality Initiative, National Kidney Foundation. Perit Dial Int 1998; 18:247-51.
12. Lo WK, Cheng IK, Lui SL, Chan TM, Li FK, Lai KN. Is target Kt/V and patient survival different between Asian and Western continuous ambulatory peritoneal dialysis (CAPD) patients? Perit Dial Int 1999; 19(Suppt 2):S27-31.
13. Johnson D, Brown F, Lammi H, Walker R. The CARI guidelines. Dialysis adequacy (PD) guidelines. Nephrology (Carlton) 2005; 10(Suppl 4):S81-107.
14. Lo WK, Ho YW, Li CS, Wong KS, Chan TM, Yu AW, et al. Effect of Kt/ V on survival and clinical outcome in CAPD patients in a randomized prospective study. Kidney Int 2003; 64:649-56.
15. NKF-DOQI Clinical practice guidelines for peritoneal dialysis adequacy. National Kidney Foundation. Am J Kidney Dis 1997; 30(3 Suppl 2):S67-136.
16. II. NKF-K/DOQI Clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 2001; 37(1 Suppl 1):S65-136.
17. McCormick BB, Bargman JM. The implications of the ADEMEX study for the peritoneal dialysis prescription: the role of small solute clearance versus salt and water removal. Curr Opin Nephrol hypertens 2003; 12:581-5.
18. Amato D, Paniagua R. The ADEMEX study: afterthoughts. Perit Dial Int 2003; 23:313-16.
19. Mujais S, Vonesh E, Abu-Alfa A. Implications of the ADEMEX trial. Contrib Nephrol 2003; 140:131-41.
20. Wang T, Lindholm B. Beyond CANUSA, DOQI, ADEMEX: what's next? Perit Dial Int 2002; 22:555-62.
21. Piraino B. ADEMEX: how should it change our practice? Perit Dial Int 2002; 22:552-4.
22. Heimburger O. The negative results of the ADEMEX study may be positive for peritoneal dialysis. Time for a paradigm shift in the focus of peritoneal dialysis adequacy? Perit Dial Int 2002; 22:546-8.
23. Blake P. ADEMEX: a landmark peritoneal dialysis study. Should we change our practice? Perit Dial Int 2002; 22:545.
24. Tzamatoukas AH, Murata GH. Adequacy of peritoneal dialysis after the ADEMEX study. Back to the basics. Int J Artif Organs 2002; 25:827-31.
25. Churchill DN. The ADEMEX Study: make haste slowly. J Am Soc Nephrol 2002; 13:1415-18.
26. National Kidney Foundation-K/DOQI. Clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis 2006; 48(Suppl 1):S98-129.
27. Dombros N, Dratwa M, Feriani M, Gokal R, Heimburger O, Krediet R, et al. European best practice guidelines for peritoneal dialysis. 7 Adequacy of peritoneal dialysis. Nephrol Dial Transplant 2005; 20(Suppl 9):ix24-7.
28. Clinical practice guidelines for nutrition in chronic renal failure. K/ DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35(Suppl 1):S1-140.